A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia

Mark A. Weiss, Timothy B. Aliff, Martin S. Tallman, Stanley R. Frankel, Matt E. Kalaycio, Peter G. Maslak, Joseph G. Jurcic, David A. Scheinberg, Todd E. Roma

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences